Literature DB >> 26375763

Associating portal embolization and artery ligation to induce rapid liver regeneration in staged hepatectomy.

A Dupré1,2, M Hitier1, P Peyrat1, Y Chen1, P Meeus1, M Rivoire1,2,3.   

Abstract

BACKGROUND: Insufficient volume of the future liver remnant (FLR) is a major cause of unresectability in patients with bilobar colorectal liver metastases (CLM). The objective of this study was to evaluate the safety and efficacy of the novel associating portal embolization and artery ligation (APEAL) technique before extended right hepatectomy during a two-stage procedure for CLM.
METHODS: All patients who had undergone extended right hepatectomy during two-stage surgery for CLM between 2012 and 2014 were identified retrospectively from a prospectively maintained database. In the first stage, right portal vein embolization, partial right hepatic artery ligation and devascularization of segment IVb along the round ligament without parenchymal transection were associated with clearance of the FLR and/or primary tumour resection. Liver volumetry was performed using OsiriX software on postoperative day (POD) 7 and 30.
RESULTS: Ten patients underwent the APEAL procedure. During the first stage, APEAL was combined with colorectal resection in seven patients. The median (range) interval between the two stages was 45 (31-71) days. The FLR volume increased from 327 (214-537) cm(3) before surgery to 590 (508-1072) cm(3) on POD 7 and 701 (512-1018) cm(3) on POD 30. This corresponded to a FLR regeneration rate of 104 (42-185) and 134 (53-171) per cent respectively. There were no deaths. The overall morbidity rate was 60 per cent (6 of 10) after each procedure, with severe morbidity occurring in two and three of ten patients after the first and second procedures respectively.
CONCLUSION: APEAL induces fast, safe, reproducible and effective FLR growth when an extended right hepatectomy is scheduled in patients with multiple bilobar CLM.
© 2015 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26375763     DOI: 10.1002/bjs.9900

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

Review 1.  Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases.

Authors:  Guillaume Passot; Olivier Soubrane; Felice Giuliante; Giuseppe Zimmitti; Diane Goéré; Suguru Yamashita; Jean-Nicolas Vauthey
Journal:  Liver Cancer       Date:  2016-11-29       Impact factor: 11.740

2.  Combined Preoperative Portal and Hepatic Vein Embolization (Biembolization) to Improve Liver Regeneration Before Major Liver Resection: A Preliminary Report.

Authors:  Bertrand Le Roy; Antoine Perrey; Mikael Fontarensky; Johan Gagnière; Armand Abergel; Bruno Pereira; Celine Lambert; Louis Boyer; Denis Pezet; Pascal Chabrot; Emmanuel Buc
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

Review 3.  Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition).

Authors:  Hui-Chuan Sun; Jian Zhou; Zheng Wang; Xiufeng Liu; Qing Xie; Weidong Jia; Ming Zhao; Xinyu Bi; Gong Li; Xueli Bai; Yuan Ji; Li Xu; Xiao-Dong Zhu; Dousheng Bai; Yajin Chen; Yongjun Chen; Chaoliu Dai; Rongping Guo; Wenzhi Guo; Chunyi Hao; Tao Huang; Zhiyong Huang; Deyu Li; Gang Li; Tao Li; Xiangcheng Li; Guangming Li; Xiao Liang; Jingfeng Liu; Fubao Liu; Shichun Lu; Zheng Lu; Weifu Lv; Yilei Mao; Guoliang Shao; Yinghong Shi; Tianqiang Song; Guang Tan; Yunqiang Tang; Kaishan Tao; Chidan Wan; Guangyi Wang; Lu Wang; Shunxiang Wang; Tianfu Wen; Baocai Xing; Bangde Xiang; Sheng Yan; Dinghua Yang; Guowen Yin; Tao Yin; Zhenyu Yin; Zhengping Yu; Bixiang Zhang; Jialin Zhang; Shuijun Zhang; Ti Zhang; Yamin Zhang; Yubao Zhang; Aibin Zhang; Haitao Zhao; Ledu Zhou; Wu Zhang; Zhenyu Zhu; Shukui Qin; Feng Shen; Xiujun Cai; Gaojun Teng; Jianqiang Cai; Minshan Chen; Qiang Li; Lianxin Liu; Weilin Wang; Tingbo Liang; Jiahong Dong; Xiaoping Chen; Xuehao Wang; Shusen Zheng; Jia Fan
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

4.  Portal supply of segment IV of the liver based on CT-scan.

Authors:  Roxane Maurer; Michel Rivoire; Valéria Basso; Pierre Meeus; Patrice Peyrat; Aurélien Dupré
Journal:  Surg Radiol Anat       Date:  2016-10-18       Impact factor: 1.246

5.  Partial ALPPS with a longer wait between procedures is safe and yields adequate future liver remnant hypertrophy.

Authors:  Nagappan Kumar; Trish Duncan; David O'Reilly; Zsolt Káposztás; Craig Parry; John Rees; Sameer Junnarkar
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2019-02-28

6.  Assessment of remnant liver function and volume after selective ligation of portal vein and hepatic artery in a rat model.

Authors:  Thiago Boechat de Abreu; Alexandre de Abreu Ribeiro; Lívia Paola Colchete Provenzano; Joaquim Ribeiro Filho; Alberto Schanaider
Journal:  Acta Cir Bras       Date:  2020-01-10       Impact factor: 1.388

7.  Evaluation of liver regeneration and post-hepatectomy liver failure after hemihepatectomy in patients with hepatocellular carcinoma.

Authors:  Wen-Feng Gong; Jian-Hong Zhong; Zhan Lu; Qiu-Ming Zhang; Zhi-Yuan Zhang; Chang-Zhi Chen; Xu Liu; Liang Ma; Zhi-Ming Zhang; Bang-De Xiang; Le-Qun Li
Journal:  Biosci Rep       Date:  2019-08-23       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.